Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05453799
Title Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Northwestern University
Indications

thyroid gland Hurthle cell carcinoma

thyroid gland anaplastic carcinoma

Therapies

XmAb20717

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST